U.S. Moves to Ease Ethylene Oxide Limits, Balancing Medical Supply Needs and Health Risks

The Trump administration has proposed easing restrictions on ethylene oxide, a cancer-causing gas widely used to sterilize medical equipment, in a move aimed at supporting the healthcare supply chain while raising fresh public health concerns.

The U.S. Environmental Protection Agency said the revised rule would offer greater flexibility to medical device manufacturers, allowing them to choose between installing advanced monitoring systems or modifying ventilation in facilities that use large volumes of the gas. Officials argue the changes would reduce compliance burdens, save an estimated $43 million annually, and ensure the continued availability of critical medical supplies such as heart stents and wound dressings.

Ethylene oxide plays a crucial role in sterilizing nearly half of all medical devices in the United States. However, long-term exposure to the gas has been linked to increased cancer risks, particularly for communities located near sterilization facilities.

The proposal marks a shift from stricter regulations introduced in 2024 under the Biden administration, which required additional risk assessments and mandated new monitoring technologies and containment systems. Those rules faced pushback from the medical industry and the U.S. Food and Drug Administration, which warned that overly stringent standards could disrupt device sterilization and impact patient care.

The EPA said the updated approach seeks to balance public health protections with operational realities in the medical sector. The proposal will undergo a public hearing in the coming weeks and remain open for comment for 45 days before a final decision is made.

The outcome could have significant implications for both environmental safety and the resilience of the U.S. healthcare supply chain.

Easing pollutant limits creates ongoing tension between industrial supply and community-health disclosure, and it's the kind of issue that surfaces as private litigation and state-AG action even when federal rules relax. Our sustainability-due-diligence teams help clients evaluate environmental-liability exposure and align disclosure with the widening enforcement landscape.